A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects

Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease

NCT00093977 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease

NCT00925587 ·Status: COMPLETED ·Phase: PHASE3

Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease

NCT00121602 ·Status: COMPLETED ·Phase: PHASE3

Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis

NCT00111098 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease

NCT00436748 ·Status: TERMINATED ·Phase: PHASE3

Darbepoetin Alfa Once Monthly Dosing Schedule Maintains Hemoglobin Concentration Comparable to Every 2 Weeks Dosing Schedule in Advanced Chronic Kidney Disease Patients Not on Dialysis: A Multicenter, Phase 4 Study

NCT07025460 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

STAAR-1 Clinical Study

NCT00369772 ·Status: COMPLETED ·Phase: PHASE4

CKD-11101 Phase 3 SC Study

NCT03431623 ·Status: COMPLETED ·Phase: PHASE3

An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)

NCT00124098 ·Status: COMPLETED ·Phase: PHASE3

Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure

NCT00213291 ·Status: COMPLETED ·Phase: PHASE3

A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy

NCT00907608 ·Status: TERMINATED ·Phase: NA

A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis

NCT00559273 ·Status: COMPLETED ·Phase: PHASE3

Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia

NCT00563446 ·Status: COMPLETED ·Phase: NA

A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor

NCT00359840 ·Status: COMPLETED ·Phase: PHASE2

Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis

NCT00112008 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia

NCT05691257 ·Status: UNKNOWN ·Phase: PHASE4

Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)

NCT00093015 ·Status: COMPLETED ·Phase: PHASE3

Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease

NCT01652872 ·Status: COMPLETED ·Phase: PHASE3

A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.

NCT00495365 ·Status: TERMINATED ·Phase: PHASE4

A Study Comparing Subcutaneous Mircera and Darbepoetin Alfa for Maintenance Treatment of Anemia in Kidney Transplant Recipients.

NCT00605345 ·Status: COMPLETED ·Phase: PHASE3

A Study of Once-Monthly Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia.

NCT00560547 ·Status: WITHDRAWN ·Phase: PHASE3

Absorption and Elimination of Radiolabeled Daprodustat

NCT03239522 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients

NCT00261521 ·Status: COMPLETED ·Phase: PHASE3

STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients

NCT00364845 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease

NCT00314795 ·Status: COMPLETED ·Phase: PHASE2